Table 1 Clinical and pathological characteristics of patients
From: Estrogen receptor α (ERα) mediates 17β-estradiol (E2)-activated expression of HBO1
characteristic | value |
|---|---|
Tumor grade(n[%]) | |
I | 45 [40.2%] |
II/III | 67 [59.8%] |
Ki67 status(n[%]) | |
negative | 50 [44.6%] |
positive | 62 [55.4%] |
Estrogen receptor α status(n[%]) | |
negative | 39 [34.8%] |
positive | 73 [65.2%] |
Progesterone receptor status(n[%]) | |
negative | 60 [53.6%] |
positive | 52 [46.4%] |
P53 status(n[%]) | |
Negative | 62 [55.4%] |
Positive | 50 [44.6%] |
HBO1 status(n[%]) | |
negative | 48 [42.9%] |
positive | 64 [57.1%] |
Histology Grade (n[%]) | |
G1 | 32 [28.6%] |
G2/G3 | 80 [71.4%] |